Hematology/Oncology and Stem Cell Therapy is a peer-reviewed english-language open-access journal published by Wolters Kluwer Medknow Publications in India, operating under an open-access model since 2008. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors publish in Hematology/Oncology and Stem Cell Therapy without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-SA license (see other journals using this license).
Keywords
hematology, oncology, stem cell, hematopoietic, solid tumors, hematologic disorder
At a glance
- Publisher
- Wolters Kluwer Medknow Publications
- Country
- India
- Primary language
- English
- License
- CC BY-NC-SA
- Peer review
- Double anonymous peer review
- OA since
- 2008
ISSN
- 1658-3876
- electronic
- 2589-0646
Frequently asked questions
Is Hematology/Oncology and Stem Cell Therapy peer-reviewed?
Yes — Hematology/Oncology and Stem Cell Therapy operates a Double anonymous peer review review process.
Does Hematology/Oncology and Stem Cell Therapy charge an article processing charge (APC)?
No. Hematology/Oncology and Stem Cell Therapy does not charge any APC. Publication is free for accepted authors.
What subjects does Hematology/Oncology and Stem Cell Therapy publish?
Hematology/Oncology and Stem Cell Therapy publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Hematology/Oncology and Stem Cell Therapy accept?
Hematology/Oncology and Stem Cell Therapy accepts manuscripts in English.
What is the ISSN of Hematology/Oncology and Stem Cell Therapy?
ISSN:
1658-3876 (print) · 2589-0646 (electronic).How do I submit a manuscript to Hematology/Oncology and Stem Cell Therapy?
Submit through the journal's official portal: visit submission page →